Stay updated on NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.

Latest updates to the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page
- Check3 days agoChange DetectedThe page history now shows Revision: v3.3.4 replacing Revision: v3.3.3 in the history header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded Revision: v3.3.3 to the page. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check46 days agoChange DetectedNew version entries on 2025-11-24 and 2025-11-25 add Contacts/Locations and Study Status to the record; a deletion occurred on 2025-08-12.SummaryDifference0.3%

- Check53 days agoChange DetectedThe Record History shows a new revision label (v3.3.2) and the removal of the previous entry (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe site-wide notice about government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedNew version entry dated 2025-08-10 adds updates to Study Status and Contacts/Locations in the record history, expanding the list of changes for this trial.SummaryDifference0.1%

Stay in the know with updates to NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NNC6019-0001 in TTR Amyloidosis: Safety & Efficacy Clinical Trial page.